The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: methylprednisolone     Quarter: 2016Q3

Total Drug/Injury Combinations: 857     Number of Pages: 43

DRUGNAME PT EventCount
METHYLPREDNISOLONE. Type 2 diabetes mellitus 1 view events
METHYLPREDNISOLONE. Umbilical cord vascular disorder 1 view events
METHYLPREDNISOLONE. Underdose 1 view events
METHYLPREDNISOLONE. Upper gastrointestinal haemorrhage 1 view events
METHYLPREDNISOLONE. Upper-airway cough syndrome 1 view events
METHYLPREDNISOLONE. Urinary sediment present 1 view events
METHYLPREDNISOLONE. Urosepsis 1 view events
METHYLPREDNISOLONE. Urticaria 1 view events
METHYLPREDNISOLONE. Vaginal haemorrhage 1 view events
METHYLPREDNISOLONE. Vascular rupture 1 view events
METHYLPREDNISOLONE. Venoocclusive liver disease 1 view events
METHYLPREDNISOLONE. Venous thrombosis limb 1 view events
METHYLPREDNISOLONE. Viraemia 1 view events
METHYLPREDNISOLONE. Viral sepsis 1 view events
METHYLPREDNISOLONE. Vitritis 1 view events
METHYLPREDNISOLONE. White blood cells urine positive 1 view events
METHYLPREDNISOLONE. Withdrawal syndrome 1 view events

Total Drug/Injury Combinations: 857     Number of Pages: 43

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)